PAXIP1 Antikörper (AA 613-812)

Produktnummer ABIN7162702

Produktdetails anti-PAXIP1 Antikörper

Target: PAXIP1 (PAX Interacting (With Transcription-Activation Domain) Protein 1 (PAXIP1))

Bindungsspezifität: AA 613-812

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser PAXIP1 Antikörper ist unkonjugiert

Applikation: ELISA, Immunohistochemistry (IHC)

Kreuzreaktivität: Human

Aufreinigung: >95%, Protein G purified

Immunogen: Recombinant Human PAX-interacting protein 1 protein (613-812AA)

Isotyp: IgG

Anwendungsinformationen

Applikationshinweise: Recommended dilution: IHC:1:20-1:200,

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Liquid

Buffer: Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Lagerung: -20 °C,-80 °C

Informationen zur Lagerung: Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.

Details zu PAXIP1

Target: PAXIP1 (PAX Interacting (With Transcription-Activation Domain) Protein 1 (PAXIP1))

Andere Bezeichnung: PAXIP1 (PAXIP1 Produkte)

Synonyme: CAGF29 antikoerper, PACIP1 antikoerper, PAXIP1L antikoerper, PTIP antikoerper, TNRC2 antikoerper, wu:fa04b06 antikoerper, zgc:92593 antikoerper, cagf28 antikoerper, cagf29 antikoerper, k14 antikoerper, pacip1 antikoerper, paxip1l antikoerper, ptip antikoerper, tnrc2 antikoerper, D5Ertd149e antikoerper, PAX interacting protein 1 antikoerper, PAX interacting (with transcription-activation domain) protein 1 antikoerper, PAX interacting protein 1 L homeolog antikoerper, PAXIP1 antikoerper, paxip1 antikoerper, paxip1.L antikoerper, Paxip1 antikoerper

Hintergrund:

Background: Involved in DNA damage response and in transcriptional regulation through histone methyltransferase (HMT) complexes. Plays a role in early development. In DNA damage response is required for cell survival after ionizing radiation. In vitro shown to be involved in the homologous recombination mechanism for the repair of double-strand breaks (DSBs). Its localization to DNA damage foci requires RNF8 and UBE2N. Recruits TP53BP1 to DNA damage foci and, at least in particular repair processes, effective DNA damage response appears to require the association with TP53BP1 phosphorylated by ATM at \'Ser-25\'. Together with TP53BP1 regulates ATM association. Recruits PAGR1 to sites of DNA damage and the PAGR1:PAXIP1 complex is required for cell survival in response to DNA damage, the function is probbaly independent of MLL-containing histone methyltransferase (HMT) complexes. Promotes ubiquitination of PCNA following UV irradiation and may regulate recruitment of polymerase eta and RAD51 to chromatin after DNA damage. Proposed to be involved in transcriptional regulation by linking MLL-containing histone methyltransferase (HMT) complexes to gene promoters by interacting with promoter-bound transcription factors such as PAX2. Associates with gene promoters that are known to be regulated by KMT2D/MLL2. During immunoglobulin class switching in activated B-cells is involved in trimethylation of histone H3 at \'Lys-4\' and in transcription initiation of downstream switch regions at the immunoglobulin heavy-chain (Igh) locus, this function appears to involve the recruitment of MLL-containing HMT complexes.

Aliases: CAGF 28 antibody, CAGF 29 antibody, CAGF28 antibody, CAGF29 antibody, FLJ41049 antibody, PACIP 1 antibody, PACIP1 antibody, PAX interacting (with transcription activation domain) protein 1 antibody, PAX interacting protein 1 antibody, PAX transactivation activation domain-interacting protein antibody, PAX transcription activation domain interacting protein 1 like antibody, PAX-interacting protein 1 antibody, PAXI1_HUMAN antibody, PAXIP 1 antibody, PAXIP 1L antibody, paxip1 antibody, PAXIP1 protein antibody, PAXIP1L antibody, Protein encoded by CAG trinucleotide repeats antibody, PTIP antibody, TNRC 2 antibody, TNRC2 antibody

UniProt: Q6ZW49

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Production of Molecular Mediator of Immune Response